Boosting research and innovation in a changing regulatory framework
The current scenario for clinical research is challenging. A new regulatory framework for clinical research in Europe is crucial to create a favourable environment for innovation and for development of high quality, safe and effective medicines in the interest of patients. Starting from this premise, the XV Foresight Training Course “Boosting research and innovation in a changing regulatory framework”, will run as a hybrid meeting on 15-16 December 2022 in Bari and online. The course aims to highlight the efforts made in Europe to foster research and innovation in a changing scientific, social and economic setting with a focus on:
- clinical research, as expected from the new Clinical Trials Regulation implementation and the Accelerating Clinical Trials in the EU initiative
- innovative methodologies including digital and in silico approaches, implemented into all the phases of drugs development, with an insight on the paediatric and rare diseases research
- the challenges and opportunities of the use of Real-World Data and of a patient-centric model to boost research and innovation
Relevant experts in the field, including representatives from the European Institutions, academia, companies and patients will provide their contribution to the discussion, aimed to gather the point of view of all the stakeholders involved in the medicine research & development process.
How these perspectives will be implemented to enhance the needed transformation?
The course is free of charge for students, researchers, representatives from patients’ associations and not for profit organisations.
A registration fee is foreseen for participants from for-profit organisations only.
Registration fee (Deadline: 2 December 2022):
– €200 per person
– €500 group fee (minimum 3 participants; maximum 6 participants)
Università degli Studi di Bari Aldo Moro has accredited the Course that will provide post-graduate students with educational credits.
For more information contact us at firstname.lastname@example.org